Sabra Health Care REIT (SBRA) Mortgage Loans (2012 - 2026)

Sabra Health Care REIT's Mortgage Loans history runs 15 years deep, the most recent figure standing at $432.9 million for Q1 2026.

• On a quarterly basis, Mortgage Loans fell 2.53% year-over-year to $432.9 million in Q1 2026; TTM through Mar 2026 was $432.9 million, a 2.53% decrease from a year earlier, with the FY2025 full-year figure at $434.1 million, down 1.92% from the prior year.
• Mortgage Loans steadied at $432.9 million in Q1 2026 per SBRA's latest filing, from $434.1 million in the prior quarter.
• Across five years, Mortgage Loans topped out at $444.2 million in Q1 2025 and bottomed at $390.3 million in Q3 2022.
• The 5-year median for Mortgage Loans is $422.5 million (2024), against an average of $423.1 million.
• Across the five-year window, Mortgage Loans jumped 292.27% in 2022 and declined 2.53% in 2026, its largest moves.
• Year by year, Mortgage Loans stood at $411.4 million in 2022, then climbed by 2.24% to $420.6 million in 2023, then climbed by 5.22% to $442.6 million in 2024, then slipped by 1.92% to $434.1 million in 2025, then dropped by 0.27% to $432.9 million in 2026.
• Per Business Quant, the three latest SBRA Mortgage Loans figures stand at $432.9 million (Q1 2026), $434.1 million (Q4 2025), and $436.5 million (Q3 2025).